COVID-19
Researchers at Regeneron Pharmaceuticals Inc. have explored the use of lipid nanoparticles (LNPs) in the delivery of nucleic acids, including the first RNAi drug and two COVID-19 mRNA vaccines approved by the FDA. Despite their advantages, challenges such as liver accumulation and difficulties in quality control persist for LNP development.
COVID-19
A recent study from Arizona State University has shed new light on the relationship between authoritarian personality traits and resistance to public health measures during the COVID-19 pandemic. The research, published in the Political Research Quarterly in 2024, suggests that individuals with authoritarian dispositions are more likely to oppose pandemic
COVID-19
A new study on COVID-19 vaccines has found that a single dose of the original mRNA vaccine provides similar protection to two doses for immunocompetent individuals aged 5 years in the current setting of high pre-existing immunity. This supports current recommendations for one dose to be given in advance of
COVID-19
Research from the University of Sao Paulo has uncovered a complex mechanism by which the SARS-CoV-2 virus exploits the host cell's endoplasmic reticulum (ER) to replicate and evade the immune system. A study published in the Journal of Proteomics found that the Brazilian variants of the virus, known
COVID-19
Research conducted at Hunan Agricultural University in China has highlighted the significance of detecting asymptomatic infections in controlling the spread of COVID-19. The study proposed a new mathematical model for virus transmission with asymptomatic infected persons, which can be used for COVID-19. According to the researchers, the model shows that
COVID-19
Research conducted by the University of Utrecht's Julius Center for Health Sciences and Primary Care has found that preexisting antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provide some protection against infection with the Omicron BA.1/BA.2 variant, but have no significant effect on symptom
COVID-19
Research conducted by Hiroshima University has found that various countries and institutions employed different strategies to support the mental health of healthcare workers (HCWs) during the COVID-19 pandemic. The study, which analyzed 34 articles from esteemed databases, revealed that mental health consultation services, group activities, and peer support strategies played
COVID-19
A study conducted in 2023 involving a nationally representative sample of 2528 parents of children aged 0-12 years across Canada found that vaccine uptake prevalence rate was 86.39% among the participants. However, significant differences in vaccination prevalence for racialized parents were observed, highlighting the need for inclusive strategies that
COVID-19
A damning report by US Senator Ron Johnson reveals that American health authorities were aware of a potential link between the Pfizer and Moderna COVID-19 vaccines and serious heart-related side effects as early as February 2021, yet delayed warning the public for months. The findings have sparked concerns about whether
COVID-19
A study published in the journal Vaccine reveals that the COVID-19 pandemic has significantly impacted influenza vaccine uptake dynamics in high-risk groups in Kyrgyzstan. The research, conducted by the Task Force for Global Health, analyzed data from 7,200 individuals and found that the pandemic has altered socio-demographic predictors and
COVID-19
As the United States embarks on a new phase in its COVID-19 response, the Food and Drug Administration (FDA) has announced a significant shift in its stance on who should receive the COVID-19 vaccine. Effective May 20, 2025, the FDA will only approve new versions of the vaccine for adults
COVID-19
New research has shed light on the mechanisms underlying the development of monoclonal antibody responses elicited by COVID-19 vaccination and natural infection. Investigators from the Southern University of Science and Technology (SUSTech) have investigated the monoclonal antibody responses elicited by wild-type SARS-CoV-2 inactivated vaccination compared to those elicited by natural
